MPN-375 BET Inhibitor Pelabresib (CPI-0610) Combined With Ruxolitinib in Patients With Myelofibrosis – JAK Inhibitor-Naïe or With Suboptimal Response to Ruxolitinib – Preliminary Data From the MANIFEST Study

John Mascarenhas, Marina Kremyanskaya, Andrea Patriarca, Claire Harrison, Prithviraj Bose, Raajit K. Rampal, Francesca Palandri, Timothy Devos, Francesco Passamonti, Gabriela Hobbs, Moshe Talpaz, Alessandro M. Vannucchi, Jean‐Jacques Kiladjian, Srđan Verstovšek, Ron Hoffman, Mohamed E. Salama, Dong Chen, Pietro Taverna, Alex R. Chang, Gozde Colak, Sandra Klein, Vikas Gupta